Faron Pharmaceuticals Oy (LON:FARN – Get Free Report)’s stock price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 42.11 and traded as high as GBX 43. Faron Pharmaceuticals Oy shares last traded at GBX 40.90, with a volume of 233,242 shares changing hands.
Faron Pharmaceuticals Oy Price Performance
The company has a current ratio of 0.84, a quick ratio of 1.09 and a debt-to-equity ratio of -133.35. The firm has a market cap of £82.98 million, a price-to-earnings ratio of -1.85 and a beta of 1.12. The company’s 50-day moving average is GBX 42.11 and its 200-day moving average is GBX 58.92.
About Faron Pharmaceuticals Oy
Faron (AIM: FARN, First North: FARON) is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The Company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and organ damage. Clevegen (bexmarilimab), its investigative precision immunotherapy, is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation in various conditions, with potential across oncology, infectious disease and vaccine development.
Featured Stories
- Five stocks we like better than Faron Pharmaceuticals Oy
- Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of War
- AI Cold War Catches Light: Federal Friction in the Server Rack
- 3 Stocks Whose Charts May Be Signaling the Next Big Move
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
Receive News & Ratings for Faron Pharmaceuticals Oy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Faron Pharmaceuticals Oy and related companies with MarketBeat.com's FREE daily email newsletter.
